CardieX Limited announced two new senior appointments to CardieX's management team who will support the company as it rapidly moves forward to execute on its global growth strategy, increase revenue, strengthen global business initiatives, and bolster the company's position in high-value,high-growth health markets. Senior health executive Chris Dax has been appointed to the role of Vice President of Operations. Chris has extensive pharmaceutical, biological and medical device, commercial, and general management experience with a proven track record of exceeding business and sales objectives. The company has also appointed Sean Merritt, PhD to the role of Director of Product Innovation to support CardieX as it moves to launch new products into global health markets. Sean was most recently a Director of Research and Development for Cercacor's consumer non-invasive patient technology device business where he was responsible for engineering, design, and product development of Cercacors medical and direct to consumer (D2C) device solutions.